Improving Colorectal Cancer Screening for Diverse Hispanics in Urban Primary Care
Improving Colorectal Cancer (CRC) Screening for Diverse Hispanics in an Urban Primary Care Setting
1 other identifier
interventional
386
1 country
1
Brief Summary
The proposed study seeks to investigate the impact of a culturally targeted print educational intervention on rates of colorectal cancer (CRC) screening via colonoscopy among Hispanics. If, as expected, the addition of culturally targeted materials to best clinical practices as compared to a) best clinical practices plus standard materials or b) best clinical practices alone leads to higher rates of CRC screening via colonoscopy then the culturally targeted print educational materials can be easily disseminated among this rapidly growing minority group who have low rates of CRC screening and whose disease is detected at later, less curable stages.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2012
CompletedStudy Start
First participant enrolled
April 1, 2012
CompletedFirst Posted
Study publicly available on registry
April 3, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedJanuary 29, 2016
January 1, 2016
3.7 years
March 29, 2012
January 28, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline of colonoscopy at 3 months, 6 months, and 12 months.
Comparison of physician recommended colonoscopy (post intervention) obtained at approximately 3 months and 6 months (via self report) and at 12 months (as per chart review), to that of colonoscopy obtained at baseline.
Baseline, at 3 months, at 6 months, and at 12 months
Study Arms (3)
Culturally targeted print materials
ACTIVE COMPARATORBest clinical practices plus culturally print materials
Standard print materials
ACTIVE COMPARATORBest clinical practices plus standard print materials
Best clinical practices alone
ACTIVE COMPARATORBest clinical practices alone: This intervention arm includes best clinical practices (or standard/usual care at MSSM) and no additional print materials.
Interventions
This intervention arm includes best clinical practices (or usual care at MSSM) and the culturally relevant print materials developed for this study.
This intervention arm includes best clinical practices (or usual care at MSSM) and the standard CRC screening print materials developed by the Centers for Disease Control (CDC).
This intervention arm includes best clinical practices (or standard/usual care at MSSM) and no additional print materials.
Eligibility Criteria
You may qualify if:
- Self-identified Hispanic
- Between the ages of 50 and 85
- Able to provide informed consent in either English or Spanish
- No participation in study Focus Groups by a family member or oneself
- Referred for a screening colonoscopy by a primary care physician at Mount Sinai
- At average risk for developing colorectal cancer
- Have no colonoscopy procedure within the last 5 years
- Have telephone service
You may not qualify if:
- Personal history of CRC
- Personal history of any chronic GI disorder (irritable bowel syndrome, colitis) and
- Family history of CRC (first degree relative of CRC)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
Related Publications (1)
Cotter G, DuHamel K, Schofield E, Jandorf L. Processes of Change for Colonoscopy: Limited Support for Use Among Navigated Latinos. J Racial Ethn Health Disparities. 2019 Apr;6(2):327-334. doi: 10.1007/s40615-018-0528-4. Epub 2018 Oct 9.
PMID: 30302744DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Katherine DuHamel, PhD
Memorial Sloan Kettering Cancer Center
- PRINCIPAL INVESTIGATOR
Lina Jandorf, MA
Icahn School of Medicine at Mount Sinai
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 29, 2012
First Posted
April 3, 2012
Study Start
April 1, 2012
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
January 29, 2016
Record last verified: 2016-01